Medicare Enrolled

Dr. Sepi Mahooti, M.D.

Optician · San Diego, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
13922 MENNONITE PT, San Diego, CA 92129
2035067862
In practice since 2007 (18 years)
NPI: 1245446228 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mahooti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahooti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mahooti

Dr. Sepi Mahooti is an optician specialist in San Diego, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mahooti performed 9,380 Medicare services across 6,175 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mahooti received a total of $215 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mahooti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 9% volume in CA $215 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,380
Medicare services
Top 9% in CA for optician
6,175
Unique beneficiaries
$142
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~521 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Cell examination with selective cellular enhancement
A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis.
1,951 $56 $303
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
1,634 $60 $327
Special tissue stain, multiplex
A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide.
1,404 $149 $726
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
1,313 $105 $607
Computer-assisted urine cell examination
A laboratory test that uses computer technology to analyze cells found in a urine sample.
919 $312 $1,256
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
583 $448 $1,801
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
524 $81 $511
Prostate needle biopsy pathology exam
Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities.
483 $310 $1,615
Special stain test for organisms
A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results.
225 $96 $553
Special tissue stain and interpretation
A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings.
131 $72 $376
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
93 $23 $217
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
36 $34 $105
Nucleic acid sequencing for organism identification
A laboratory test that uses nucleic acid sequencing to identify specific organisms.
12 $113 $345
Candida yeast detection and quantification test
A laboratory test that detects the presence of Candida yeast and measures the amount present in a sample.
12 $55 $170
Chlamydia trachomatis nucleic acid test, quantitative
A laboratory test that uses nucleic acid amplification to detect Chlamydia trachomatis and measure the amount of the organism present.
12 $52 $160
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
12 $34 $105
Gardnerella vaginalis detection and quantification test
A laboratory test that detects the presence of Gardnerella vaginalis bacteria and measures the amount present in a sample.
12 $41 $125
Gonorrhea nucleic acid test, quantification
A laboratory test that uses nucleic acid amplification to detect and measure the amount of gonorrhea bacteria in a sample.
12 $42 $130
Trichomonas vaginalis nucleic acid test
A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis.
12 $34 $105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2021 ↗
$215
Total received (2021-2021)
Bottom 29% in CA for optician
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$215 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$215

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$114
UROGEN PHARMA, INC.
$101
Top 3 companies account for 100.0% of 2021 payments
Associated products mentioned in payments ›
ERLEADA · JELMYTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in San Diego?
Compare opticians in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
474
Per 100K population
14.4
County median income
$102,285
Nearest hospital
AURORA SAN DIEGO
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mahooti is a mixed practice specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mahooti experienced with cell examination with selective cellular enhancement?
Based on Medicare claims data, Dr. Mahooti performed 1,951 cell examination with selective cellular enhancement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahooti receive payments from pharmaceutical companies?
Yes. Dr. Mahooti received a total of $215 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahooti's costs compare to other opticians in San Diego?
Dr. Mahooti's average Medicare payment per service is $142. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahooti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →